Conectados: Social Networks and Social Media for Vaccine Uptake
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jul 24, 2025
Trial Information
Current as of August 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is exploring different ways to share a short video about flu and COVID-19 vaccines, created with input from Indigenous community members in California. The goal is to see how people respond to the video when they receive it through different sources—such as a paid social media ad, a trusted community group, or from someone they know personally—and to understand how these sources affect trust in vaccine information. This research aims to help improve the way vaccine messages are shared, especially with Indigenous and other underserved communities.
To take part, you must be 18 years or older, live in California, and be able to watch an online video and complete a short survey in English or Spanish. After watching the video, participants will be asked a simple question about how much they trust the information and may choose to answer a few more questions about their thoughts on vaccines and how they saw the video. The study is not yet recruiting, but it offers a chance to help shape better health communication in communities that need it most.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Currently resides in California
- • Able to access and view an online video
- • Able to complete an online survey in English or Spanish For Arm 2 only (Participant Seed Arm): must have participated in the prior Aim 1 survey and consented to recontact
- Exclusion Criteria:
- • Under 18 years of age
- • Does not reside in California
- • Unable to access the internet to view the intervention video or complete the survey
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Nadia Diamond-Smith, PhD, MS
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported